 |
New regeNer8 virtual centre aims to advance regenerative medicine in the North of England
|
|
A virtual centre has been launched that aims to bring together the work of the North of England's top scientists to advance regenerative therapies. |
|
|
Anglo-Irish researchers to develop new cements to heal spinal fractures
|
|
A new collaborative project between the University of Leeds and Queen's University Belfast will develop and test biological cements to repair 'burst fractures' of the spine. |
|
|
World burn treatment market to be spurred on by bio-advancements
|
|
A new report by Kalorama Information indicates that the worldwide burn treatment market experienced growth of 7.6 percent from 2001 to 2006, reaching $1.9 billion. |
|
|
LNE/G-MED targets certification service at the orthopaedic sector
|
|
LNE/G-MED, a world leader of voluntary and statutory certification in the medical device sector, is focusing on developing the orthopaedic sector as one of its strategic targets. |
|
|
Angiotech and Symphony Medical reach biomaterials agreement
|
|
Angiotech Pharmaceuticals and Symphony Medical have entered into an exclusive licensing agreement to employ one of Angiotech's proprietary PEG-based biomaterials as part of a prophylactic therapy that mitigates the onset of post-operative atrial fibrillation (POAF) for patients undergoing coronary a |
|
|
New polymer material stops bone bleeding and reduced surgical infection risks
|
|
Ostene, a new polymer material developed by Ceremed to stop bone bleeding in surgery has been shown to reduce the risk of surgical infection according to a new research study. |
|
|
ETEX agrees a supply deal with AlloSource for DBM powder
|
|
Advanced biomaterials company, ETEX has entered into a supply agreement with AlloSource which will see AlloSource provide ETEX with Demineralized Bone Matrix (DBM) powder to be mixed with ETEX's proprietary, nanocrystalline, fast setting calcium phosphate to form EquivaBone. |
|
|
CardioTech forms new biomaterials subsidiary
|
|
CardioTech International has formed AdvanSource Biomaterials to conduct its business and align its name with its strategic focus. |
|
|
Coradyn Biosystems licenses conductive polymer technology for sensor devices
|
|
Coradyn Biosystems, a smart sensor materials company, has licensed a responsive, conductive polymer technology from the University of Texas at Austin. |
|
|
Familiar substances lead the way for global wound care growth
|
|
The worldwide wound care market, which reached $12.3 billion in 2007, is seeing growth being driven by advances in biotechnology, biomaterials and tissue engineering as new products and devices enter the market at speed. |
|
|
MICROSCIENCE 2008 – A Prohealthservicezone Special Report
|
|
Microscience 2008 has become largest exhibition and conference in Europe focusing on microscopy, imaging and analysis. A sign of the thriving nature of the event is that it has seen a 10 percent increase in exhibition space compared to the event in 2006 at a time when the overall exhibition sector |
|
|
Zeus extends operations to include bioabsorbable polymers
|
|
Fluoropolymer tubing manufacturer Zeus is expanding its operations to include bioabsorbable polymers. |
|
|
Bone graft substitute receives FDA 510(k) clearance
|
|
Pioneer Surgical Technology has received 510(k) clearance from the US FDA to market FortrOss, a novel bone graft substitute that uses nanotechnology for orthopaedic applications. |
|
|
Pioneer Surgical Technology introduces new bone graft substitute to US market
|
|
Pioneer Surgical Technology has released its FortrOss bone graft substitute to the US market. |
|
|
Medtronic introduces PEEK-based interspinous process decompression device
|
|
Medtronic has announced the US launch of the X-STOP PEEK IPD System, the first interspinous process decompression (IPD) device approved by the US FDA that offers a PEEK-Bone interface for treating the symptoms of lumbar spinal stenosis (LSS). |
|
|
NuVasive gains access to Progentix Orthobiology synthetic bone substitutes
|
|
Progentix Orthobiology has closed an investment agreement with NuVasive, a medical device company focused on developing products for minimally disruptive surgical treatments for the spine. |
|
|
Study spotlights the osteoconductive properties of Trabecular Metal Technology
|
|
Data has been released from an independent 10-year comparative clinical study that demonstrates the osteoconductive properties of Zimmer's Trabecular Metal Technology. |
|
|
ConvaTec launches advanced ribbon dressing in the USA
|
|
ConvaTec launches in the USA Aquacel Ag Dressing with Strengthening Fiber, a new advanced ribbon dressing. |
|
|
Innovia receives 510(k) to market laparoscopy device
|
|
Innovia, a privately held biomaterials-based medical device company, receives 510(k) clearance from the US Food and Drug Administration to market the InnoPort to support single port access laparoscopy. |
|
|
Biomerix biomaterial manufacturing sites receive ISO 13485 recognition
|
|
Biomerix, a medical technologies company developing products using its novel Biomerix Biomaterial, a three-dimensional scaffold for biointegrative tissue repair, receives an ISO 13485 Certificate of Registration. |
|
|
Canadian Dental Device Market report
|
|
In depth analysis of the market for dental devices in Canada to 2015 is the subject of a new report available from Research and Markets |
|
|
Top 10 medical device report available
|
|
Medical device technology market forecast by Research and Markets in its latest report |
|
|
Medical device materials to be launched at Medtec Ireland
|
|
AdvanSource is attending the Medtec Ireland Design and Manufacturing Exhibition demonstrating the latest development in polymer materials for the medical device industry |
|
|
Controlled hydrogel deposition for biosciences
|
|
Dip Pen Nanolithography enables biomedical engineering specialists to perform controlled hydrogel depositions |
|
|
AdvanSource’s polymer products comply with EC’s new TSE guidelines
|
|
AdvanSource Biomaterials, a developer of advanced polymer materials for a broad range of medical devices, declares that its polymer product lines are compliant with measures applying to the processing of certain animal waste to protect against transmissible spongiform encephalopathies as set forth i |
|
|
Medtronic agrees to acquire Osteotech
|
|
Medtronic and Osteotech sign a definitive agreement which will see Medtronic acquire Osteotech for $6.50 per share in cash for each share of Osteotech common stock. |
|
|
Cervical allograft system offers wide range of interbody options
|
|
K2M is launching its first product in the spinal biologics market, the VIKOS Cervical Allograft System. |
|
|
Nordson acquires Micromedics to develop precision dispensing solutions
|
|
Nordson completes the acquisition of St Paul, Minnesota-based Micromedics, a leader in applying and dispensing biomaterials for controlling bleeding, healing wounds and other related medical procedures. |
|
|
Biomet becomes Dutch distributor for Small Bone Innovations International
|
|
Small Bone Innovations International enters into an exclusive three-year distribution agreement in the Netherlands with Biomet Nederland, a subsidiary of Biomet, Inc., based in Dordrecht – the company’s European headquarters. |
|
|
Medtronic acquires Osteotech to boost regenerative biologics performance
|
|
Medtronic completes the acquisition of Osteotech, following payment of $6.50 per share in cash for each share of Osteotech stock, with a total transaction value of approximately $123 million. |
|
|
Medtronic acquires chitosan-dextran gel technology for future FESS developments
|
|
Medtronic completes the purchase of rights to a chitosan-dextran gel technology from Adelaide Research and Innovation (the commercial development company of the University of Adelaide) in Australia, Robinson Squidgel, and Otago Innovation (a University of Otago company) in New Zealand. |
|
|
Medisse completes biocompatibility evaluation of resorbable biomaterial
|
|
Medisse, a medical device company focused on the development of a new generation of resorbable flexible implants, completes the biocompatibility evaluation of its novel resorbable FlexiSurge biomaterial in accordance with the international ISO 10993 standards. |
|
|
AdvanSource Biomaterials agrees infusion therapy deal with Access Scientific
|
|
AdvanSource Biomaterials, a developer of advanced polymer materials for a broad range of medical devices, is entering into a multi-year supply agreement with Access Scientific, a San Diego-based healthcare company engaged in the business of developing vascular access devices that simplify and improv |
|
|
DSM develops novel scar reduction product for spine surgeries
|
|
DSM signs a joint collaboration agreement with AdeTherapeutics to accelerate the company's scar reduction and pain management product development strategy in neurosurgery, specifically in spine surgery and craniotomy. |
|
|
US orthopaedic biomaterials market to approach 4bn dollars in 2016
|
|
Market intelligence analyst, Millennium Research Group (MRG) forecasts that the US market for orthopaedic biomaterials will grow at an average of just under seven percent per year, to total approximately $4 billion by 2016. |
|
|
New wound dressing focuses on partial thickness burns
|
|
ConvaTec is introducing the AQUACEL Ag BURN dressing, which is a new wound dressing for the management of partial thickness burns (PTBs) and donor sites.
|
|
|
BSI releases new glossary of terms for cell therapy technologies
|
|
BSI and the London Regenerative Medicine Network are releasing the 2nd Edition of the Cell therapy and regenerative medicine glossary (commonly known to the industry as PAS 84 or the 'Little Purple Book'),to ensure that the sector is kept up to date with current terminology and industry best practi |
|
|
Research shows success of engineered tissue depends on where it is grown
|
|
MIT researchers led by Elazer Edelman, the Thomas D and Virginia W Cabot Professor of Health Sciences and Technology, are showing that implanted cells' therapeutic properties depend on their shape, which is determined by the type of scaffold on which they are grown. The work could allow scientists |
|
|
Merging tissue scaffold with electronic sensors improve implantable therapeutic devices
|
|
A team of researchers from MIT, Harvard University and Boston Children's Hospital is adding a new element to tissue scaffolds - electronic sensors. |
|
|
US wound care biomaterials market to expands to USD2.8bn by 2016
|
|
The growing population suffering from obesity, diabetes and hypertension will lead to increased incidence of both acute and chronic wounds, and favour adoption of wound care biomaterials in the USA forecasts market intelligence analyst, Millennium Research Group (MRG). |
|
|
Asia Pacific dental biomaterials market grows at seven percent to 2016
|
|
Medical technology market intelligence analyst, Millennium Research Group (MRG), is forecasting that despite the Japanese tsunami's negative effect on market revenues, the Asia Pacific dental biomaterials market will grow moderately at an average annual rate of 6.6 percent through 2016, due to the |
|
|
InVivo Therapeutics receives FDA approval for first human trial using biomaterials for traumatic spinal cord injury
|
|
The US Food and Drug Administration (FDA) has approved InVivo Therapeutics' Investigational Device Exemption (IDE) to begin human studies to test its biopolymer scaffold product, a technology developed to treat patients with acute, traumatic SCI. |
|
